Incontinence :: Trial of muscle-derived cell injection in women with stress urinary incontinence

Research into the use of muscle-derived stem cells to treat stress urinary incontinence has been ongoing.

Researchers from the University of Pittsburgh and the University of Toronto report completed clinical results of the first North American clinical trial using autologous muscle-derived stem cells to treat stress urinary incontinence.

Using a needle biopsy technique, skeletal muscle tissue was harvested, stem cells isolated and expanded in vitro, and then implanted in patients using a transurethral or periurethral technique. No adverse events or safety issues were identified in the population.

Leave a Comment